Neuroimaging is the cutting edge of psychiatric research, offering a window into the intricate workings of the brain. With advanced techniques such as fMRI, PET, and EEG, researchers can now map and analyze functional connectivity interactions between different brain regions shedding light on the neural networks disrupted in psychiatric conditions such as depression, anxiety, schizophrenia, and addiction. These tools show how abnormal connectivity patterns affect behavior, cognition, and emotion, opening the door to precision psychiatry. Integrating machine learning with neuroimaging further enhances the ability to predict disease trajectories, identify biomarkers, and develop personalized treatment strategies, transforming the landscape of mental health care. Psychiatry and Addiction World Conference (PAWC 2025) (June 20-22, 2025, Singapore, Hybrid Format) will feature the most innovative session on "Neuroimaging and Functional Connectivity in Addiction Psychiatry," which will highlight how neuroimaging is helping redefine the preventive strategies and create a dynamic environment for sharing of knowledge on innovative therapeutic approaches.